[144] Alignment Healthcare, Inc. SEC Filing

Rhea-AI Filing Summary

Alignment Healthcare (ALHC) Form 144 summary: The filing notifies a proposed sale of 18,600 shares of common stock on NASDAQ through Morgan Stanley Smith Barney LLC with an aggregate market value of $269,886. The filing reports 198,031,417 shares outstanding. The shares were acquired on 03/26/2021 as pre-IPO shares issued in exchange for partnership units. The filing lists an approximate date of sale of 08/11/2025 and states there were no securities sold in the past three months. By signing the notice the seller represents they do not know of any undisclosed material adverse information about the issuer.

Insights

Securities Analyst

TL;DR: Small planned sale of 18,600 ALHC shares; transaction size appears immaterial to total capitalization.

The Form 144 reports an intent to sell 18,600 common shares with an aggregate market value of $269,886. Given the reported 198,031,417 shares outstanding, this block represents a very small portion of the equity base. The filing discloses acquisition details (pre-IPO issuance on 03/26/2021) and confirms no sales in the prior three months. From a market-impact perspective, this disclosure is routine and likely not material to ALHC's valuation on its own.

Corporate Governance Expert

TL;DR: Routine insider/component sale notice with clear acquisition history and seller certification; governance disclosure is standard.

The notice provides the nature and date of acquisition (shares issued pre-IPO in exchange for partnership units) and the seller's representation regarding undisclosed material information. The filing follows Rule 144 reporting conventions and identifies a broker for the sale. There are no indications in the document of governance issues or unusual disclosure omissions based on the information provided.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	18600	269886.00	198031417	08/11/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/26/2021	Shares Issued Pre-IPO in exchange for Partnership Units	Issuer			18600	03/26/2021	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the ALHC Form 144 report?

The filing reports a proposed sale of 18,600 common shares on NASDAQ through Morgan Stanley Smith Barney LLC with an aggregate market value of $269,886.

When is the approximate date of the planned sale in the filing?

The filing lists the approximate date of sale as 08/11/2025.

How were the shares being sold originally acquired?

The shares were acquired on 03/26/2021 as pre-IPO shares issued in exchange for partnership units.

Has the filer sold any ALHC securities in the past three months?

The filing states Nothing to Report for securities sold during the past three months.

How many ALHC shares outstanding are reported in the filing?

The filing reports 198,031,417 shares outstanding.